发明名称 |
Makrolidcitrat-haltige Formulierungen mit kontrollierter Freisetzung |
摘要 |
Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also disclosed are methods for preparing, isolating and characterizing soluble and stable citrate salt of macrolides and use thereof in all solid dosage forms of macrolides. |
申请公布号 |
DE60203461(D1) |
申请公布日期 |
2005.05.04 |
申请号 |
DE2002603461 |
申请日期 |
2002.10.01 |
申请人 |
IND-SWIFT LTD., CHANDIGARH |
发明人 |
WADHWA, HARDEEP |
分类号 |
C07H17/08;A61K9/14;A61K9/16;A61K9/20;A61K9/22;A61K9/30;A61K9/36;A61K9/48;A61K31/4745;A61K31/70;A61K31/7048;A61K47/00;A61K47/10;A61K47/26;A61K47/30;A61K47/32;A61K47/38;A61P31/00;A61P31/04;(IPC1-7):A61K31/704 |
主分类号 |
C07H17/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|